Institution identification

Institution ID

37928

Institution full name and acronym

PPD Evidera

Institution countries

Sweden
United Kingdom
United States

Type of institution

Laboratory/Research/Testing facility
Non-Pharmaceutical company

Institution role

Researcher

Institution website

ENCePP partner

Yes
Institution description
PPD Evidera (part of the clinical research business of Thermo Fisher Scientific) partners with life science organizations to optimize the market access and value of their products.
The Real-World Data & Scientific Solutions (RWD&SS) team conducts feasibility studies to provide clients with a critical assessment of the data options available to identify the datasets that will best meet the client’s needs. RWD&SS also plans and implements the corresponding studies from a single or multiple data sources.
The team’s epidemiologists extract ‘real-world’ data from existing healthcare information sources and assess, among others, treatment patterns, drug and resource utilization as well as incidence and prevalence of diseases and co-morbidities.
RWD&SS researchers have expertise in analyzing data from a variety of data sources worldwide and compiling database coding algorithms.
The Real-world observational studies team collect and analyze data through both prospective and retrospective studies to inform development plans, gather patient insights, identify disease burden and unmet need, and meet post-authorization and post-marketing commitments.
PPD Evidera’s team of global scientific and operational experts prioritizes keeping up with the constantly changing RWD landscape and the availability of new data sources.
With staff from a variety of disciplines, including clinicians, epidemiologists, data analysts, biostatisticians and data technology experts, PPD Evidera enable our clients to effectively use RWD and RWE to advance their product development for successful market access and uptake.
To that end, PPD Evidera brings more than 30 years of experience and excellence.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact